Association Between Inflammatory Biomarkers in CVD Patients on Empagliflozin.

Inclusion Criteria: * Either sex, aged 18 years or older. * new-onset AHF or acute decompensation of chronic HF, * CAD (including previous myocardial infarction, previous percutaneous or surgical coronary revascularization, or angiographic evidence that one or more major coronary arteries had narrowed by 50% or more). * On empagliflozin 10 mg once daily for 6 months before the beginning of the study. Exclusion Criteria: * severe liver/ * kidney dysfunction; * severe systemic disease (such as the diseases of respiratory system/ digestive system/ nervous system etc.); * malignant tumor; * acute/ chronic infectious diseases; * autoimmune disease or connective tissue disease; * major trauma or surgical operation over the past three months.